Estradiol [horm, phsu, strd]
Intranasal [spco]
Management [ocac]
Menopause [phsf]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Nasal Spray [bodm]
Formulation [resa]
Containing [ftcn]
aqueous solution [phsu]
17beta estradiol [horm, phsu, strd]
Unique [qlco]
PULSE [clna]
PHARMACOKINETIC [resa]
Profile [lbpr]
Well [qlco]
Design [acty]
placebo-controlled [resa]
Trial [resa]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Reduced [qlco]
Severity [qlco]
Climacteric [orgf]
symptoms [ftcn]
Women [popg]
Moderate [qlco]
severe symptoms [fndg]
Menopausal [phsf]
weeks [tmco]
treatment [ftcn]
Efficacy [qlco]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Oral [spco]
Estradiol 2 MG [clnd]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Trial [resa]
Equivalent [qlco]
Efficacy [qlco]
Maintained [ftcn]
subgroup [virs]
Women [popg]
Initially [tmco]
severe symptoms [fndg]
smokers [fndg]
reductions [npop]
Atrophic mucosa [fndg]
Vaginal [bpoc]
Genitourinary symptoms [sosy]
Karyopyknosis [celf]
Index [inpr]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Observed [ftcn]
Oral [spco]
Estradiol 2 MG [clnd]
assessments [hlca]
effects [qlco]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Complications [patf]
Menopause [phsf]
Increased [qnco]
Cardiovascular disease [dsyn]
Osteoporosis [dsyn]
ONGOING [idcn]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Combined [qlco]
Progestagen [horm, phsu, strd]
effects [qlco]
Lipid [lipd]
Parameters [fndg]
Marker [clna]
Bone Resorption [ortf]
formation [biof]
Bone Mineral Density [clna]
postmenopausal [tmco]
Women [popg]
Estradiol [horm, phsu, strd]
Intranasal [spco]
effects [qlco]
Assessed [acty]
haemostatic [ortf]
Angiotensinogen [aapp, bacs]
insulin levels [lbpr]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Well [qlco]
Clinical Trials [resa]
adverse events [fndg]
Mild to moderate [qlco]
Reported [inpr]
Events [evnt]
Nasal symptoms [sosy]
Mastalgia [sosy]
Endometrial Hyperplasia [dsyn]
treatment [ftcn]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Combined [qlco]
Progestagen [horm, phsu, strd]
Mastalgia [sosy]
Withdrawal [acty]
Breakthrough Bleeding [patf]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Oral [spco]
Estradiol 2 MG [clnd]
Administered [ftcn]
Progestagen [horm, phsu, strd]
Trial [resa]
Trial [resa]
Mastalgia [sosy]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Estradiol [horm, phsu, strd]
Transdermal [ftcn]
Administered [ftcn]
Progestagen [horm, phsu, strd]
adverse events [fndg]
Treatments [topp]
Trial [resa]
Conclusions [idcn]
Estradiol [horm, phsu, strd]
Intranasal [spco]
Optimal [qlco]
Initiate [idcn]
Dose [qnco]
Severity [qlco]
menopausal symptoms [sosy]
Climacteric [orgf]
Good [qlco]
TOLERABILITY [resa]
Profile [lbpr]
Date [tmco]
Suggest [idcn]
Estradiol [horm, phsu, strd]
Intranasal [spco]
treatment option [topp]
menopausal symptoms [sosy]
